Navigation Links
Medisafe 1 Technologies Granted Eligibility Status by the Depository Trust Company
Date:8/26/2010

Medisafe 1 Technologies Granted Eligibility Status by the Depository Trust Company -- JERUSALEM, August 26, 2010 /PRNewswire-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, New Products & Services Click to view news release full screen  

Medisafe 1 Technologies Granted Eligibility Status by the Depository Trust Company

   

Medisafe Begins Trading on the Over-the-Counter Bulletin Board

JERUSALEM, August 26, 2010 /PRNewswire-FirstCall/ -- Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of a U.S. patented technology that physically prevents unauthorized administration of prescription medications, announced today that the company has been granted eligibility status by the Depository Trust Company (DTC). The DTC provides banks, brokerage firms and other institutions with an efficient means of moving securities and settling trades electronically.

In addition, the company has announced that shares of Medisafe 1 Technologies common stock have commenced trading on the OTC Bulletin Board under the symbol "MFTH".

"Medication administration errors in hospitals cause 400,000 preventable drug-related injuries and 7,000 deaths each year," said Jacob Elhadad, Chief Executive Officer of Medisafe 1 Technologies. "Medisafe technology seeks to significantly reduce instances of such injuries through the implementation of its patented syringe locking-device technology that physically prevents wrong medications from being administered to a patient.

"Today, the global syringe market is estimated at $5.6 billion annually. And legislation in the U.S. is currently mandating that the healthcare industry replace traditional syringes with safer technologies. Plus, a growing number of hospitals are implementing Barcoding Point of Care (BPOC) systems to help ensure that patients are administered the appropriate medications in the prescribed doses.

"Factoring the possibility of widespread implementation, the total potential addressable market for Medisafe technologies could exceed $1 billion per year," Elhadad added.

About Medisafe 1 Technologies

Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at http://www.sec.gov.

Contact: CEO JACOB ELHADAD +972-524440000 JACOB.ELHADAD10@GMAIL.COM
'/>"/>

SOURCE Medisafe 1 Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alere and AirStrip Technologies - a Powerful Collaboration Brings Innovative Remote Patient Monitoring to Obstetrical Care
2. OrthoAccel Technologies, Inc. Announces Definitive Distribution Agreements in Two Key Markets
3. MedClean Technologies Announces Second Quarter Results
4. BioStorage Technologies to Sponsor and Present Educational Workshops at Annual Biorepositories Conference
5. Acuo Technologies Bolsters Sales Team with Key Additions
6. Advanced Web-Based Medical Technologies Foster Better Informed Consumers, Greater Interest in Personal Health Care
7. Wound Management Technologies CellerateRX® Activated Collagen™ Debuts at the South African Diabetic Foot Working Group Congress in Cape Town
8. New Report - Telemedicine Market in Brazil, Russia, India, China (BRIC) - Advanced Technologies, Global Forecast by MarketsandMarkets
9. Patient Safety Technologies Reports Second Quarter 2010 Results
10. Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
11. China Medical Technologies Reports First Fiscal Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
Breaking Medicine News(10 mins):